LASTACAFT Trademark

Trademark Overview

On Wednesday, November 3, 2010, a trademark application was filed for LASTACAFT with the United States Patent and Trademark Office. The USPTO has given the LASTACAFT trademark a serial number of 85168259. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, May 26, 2021. This trademark is owned by Allergan, Inc.. The LASTACAFT trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations for the prevention and treatment of itching associated with allergic conjunctivitis
lastacaft

General Information

Serial Number85168259
Word MarkLASTACAFT
Filing DateWednesday, November 3, 2010
Status800 - REGISTERED AND RENEWED
Status DateWednesday, May 26, 2021
Registration Number4071760
Registration DateTuesday, December 13, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2011

Trademark Statements

Description of MarkThe mark consists of a depiction of an eye above the word "LASTACAFT".
Goods and ServicesOphthalmic preparations for the prevention and treatment of itching associated with allergic conjunctivitis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 6, 2010
Primary Code005
First Use Anywhere DateMonday, November 1, 2010
First Use In Commerce DateMonday, November 1, 2010

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Wednesday, May 26, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 26, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, May 26, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, May 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 17, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, December 13, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 10, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 10, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 10, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 5, 2017TEAS SECTION 8 & 15 RECEIVED
Thursday, January 5, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 13, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 7, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, October 29, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 15, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 15, 2011FINAL REFUSAL E-MAILED
Thursday, September 15, 2011SU - FINAL REFUSAL - WRITTEN
Wednesday, July 27, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 13, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2011NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2011SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 8, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, June 3, 2011USE AMENDMENT FILED
Tuesday, June 7, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 3, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, May 3, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2011PUBLISHED FOR OPPOSITION
Monday, January 31, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 28, 2011ASSIGNED TO LIE
Wednesday, December 29, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 22, 2010ASSIGNED TO EXAMINER
Tuesday, November 9, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Saturday, November 6, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 6, 2010NEW APPLICATION ENTERED

Related Keywords

lastacaft associated allergic conjunctivitis itching treatment preparations prevention ophthalmic